O. V. Mikenin
O. V. Mikenin has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- A. A. Moskovskij
State Research Center – Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; National Research Nuclear University MEPhI
1 shared publication - D. A. Bocharov
Russian State Agrarian University – Moscow Timiryazev Agricultural Academy
1 shared publication - E. D. Rodionova
Dmitry Mendeleev University of Chemical Technology of Russia
1 shared publication - Leonid Aleksandrovich Romodin
State Research Center – Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency
1 shared publication - Olga V. Nikitenko
State Research Center – Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; State Research Center – Institute of Biomedical Problems of Russian Academy of Sciences
1 shared publication - Taisia M. Bychkova
State Research Center – Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; State Research Center – Institute of Biomedical Problems of Russian Academy of Sciences
1 shared publication
Latest Publications
- Open Access
- 1 March 2026
- Published by Kazan Federal University in Uchenye Zapiski Kazanskogo Universiteta. Seriya Estestvennye Nauki
- Vol. 168 (1) , 21-41
Comparison of the radioprotective effects of copper chlorophyllin, riboxin, indralin, and the combined use of glutathione and ascorbic acid based on the physiological parameters in mice exposed to fractionated irradiation
The radioprotective effects of copper chlorophyllin, riboxin, indralin, and the combined use of glutathione and ascorbic acid were compared in male ICR (CD-1) mice exposed to five daily irradiations at doses of 1.4 or 2.5 Gy, with all compounds administered on the days of irradiation. The radioprotective efficacy was assessed three days following the final exposure using hematological parameters, thymus and spleen weights, number of nucleated cells in the bone marrow of the femur, and content of thiobarbituric acid reactive substances (TBARS) in the liver. Riboxin, administered at 200 µg/g after each irradiation, showed contradictory effects in the TBARS test, increasing oxidative stress at 1.4 Gy and suppressing it at 2.5 Gy. Copper chlorophyllin was as efficient in inhibiting the metabolism of lipid radiotoxins as classical antioxidants, glutathione and ascorbic acid. In certain cases, the compounds exhibited an ability to somewhat alleviate radiation-induced pancytopenia. Indralin, an emergency radioprotector, had no consistent radioprotective superiority across the assessed physiological parameters of mice under fractionated irradiation. The ambiguity of the observed effects highlights the need for further comprehensive research to clarify the influence of the analyzed compounds on the course of radiation sickness under various experimental conditions.
- 1 March 2026
- Published by Kazan Federal University in Uchenye Zapiski Kazanskogo Universiteta. Seriya Estestvennye Nauki
- Vol. 168 (1) , 21-41
Open AccessComparison of the radioprotective effects of copper chlorophyllin, riboxin, indralin, and the combined use of glutathione and ascorbic acid based on the physiological parameters in mice exposed to fractionated irradiation
The radioprotective effects of copper chlorophyllin, riboxin, indralin, and the combined use of glutathione and ascorbic acid were compared in male ICR (CD-1) mice exposed to five daily irradiations at doses of 1.4 or 2.5 Gy, with all compounds administered on the days of irradiation. The radioprotective efficacy was assessed three days following the final exposure using hematological parameters, thymus and spleen weights, number of nucleated cells in the bone marrow of the femur, and content of thiobarbituric acid reactive substances (TBARS) in the liver. Riboxin, administered at 200 µg/g after each irradiation, showed contradictory effects in the TBARS test, increasing oxidative stress at 1.4 Gy and suppressing it at 2.5 Gy. Copper chlorophyllin was as efficient in inhibiting the metabolism of lipid radiotoxins as classical antioxidants, glutathione and ascorbic acid. In certain cases, the compounds exhibited an ability to somewhat alleviate radiation-induced pancytopenia. Indralin, an emergency radioprotector, had no consistent radioprotective superiority across the assessed physiological parameters of mice under fractionated irradiation. The ambiguity of the observed effects highlights the need for further comprehensive research to clarify the influence of the analyzed compounds on the course of radiation sickness under various experimental conditions.